2011 Brinker Awards for Scientific Distinction
We were delighted Thursday evening to honor two of the nation’s top breast cancer researchers with Susan G. Komen’s Brinker Awards for Scientific Distinction. It capped a big week of exciting breast cancer research news at the biggest breast cancer symposium of the year — the San Antonio Breast Cancer Symposium.
This year’s Brinker Award winners are (from left), Dr. Carlos Arteaga of Vanderbilt University and Dr. Armando Giuliano of Cedars-Sinai Medical Center. Arteaga received the Brinker Award for Translational and Basic Science for identifying several key proteins that have led to many new targeted therapies for women with the disease. Giuliano was honored with the Brinker Award for Scientific Distinction in Clinical Research for his groundbreaking work that has led to less invasive surgical treatments for breast cancer. Each also delivered lectures about their work at the Symposium. More than 7,000 researchers, practitioners and advocates gathered in San Antonio for the 34th Symposium.
In remarks to the awards audience, Komen President Liz Thompson highlighted the results of a Komen-funded Institute of Medicine study, also released at the conference, into environmental factors in breast cancer, and said Komen is challenging other breast cancer research funders to join Komen in further environmental research. The Institute of Medicine study identified several lifestyle factors with proven links to breast cancer — among them obesity, lack of exercise, smoking and excessive alcohol use — and recommended long-term studies to get more conclusive evidence on how chemicals and other substances contribute to breast cancer risk.
About the author
Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen and launched the global breast cancer movement. Today, Komen is the world’s largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the Cure®, we have invested more than $1.9 billion to fulfill our promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world.